Clinical study of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patent ductus arteriosus

Cao, Hua; Chen, Qiang; Zhang, Gui Can; Chen, Liang Wan; Xu, Fan; Zhang, Jiaxin

doi:10.14744/anatoljcardiol.2018.90001

Cited by 6 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Binobaidan et al ( 12 ), Cao et al ( 20 ), and Ye et al ( 21 ) showed success rates of 100% in PDA closure, while only Zhang et al ( 22 ) showed a success rate of 97.1%. These results were similar to our study in which all the procedures were successful in both echocardiography and fluoroscopy groups.…”

Section: Discussionmentioning

confidence: 99%

“…These results were similar to our study in which all the procedures were successful in both echocardiography and fluoroscopy groups. Most studies showed no residual shunt and severe complications after 1 month to 2 years of follow-up ( 12 , 20 – 22 ). Pan et al had 8 cases of small residual shunts in 24 h but resolved afterward ( 6 ).…”

Section: Discussionmentioning

confidence: 99%

“…Pan et al had 8 cases of small residual shunts in 24 h but resolved afterward ( 6 ). The minor complications in these studies include device embolization, acute occluder dislodgement, and small residual shunts ( 6 , 12 , 20 – 22 ). In our study, there were no complications following echocardiography-guided PDA closures with most of the patients only experiencing residual shunts, which disappeared during follow-up.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Echocardiography-Guided Percutaneous Patent Ductus Arteriosus Closure: 1-Year Single Center Experience in Indonesia

Siagian

Prakoso

Putra

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

IntroductionSince the first successful percutaneous closure under transesophageal echocardiographic (TEE) guidance, many centers explored transcatheter procedures without fluoroscopy. This single-center study is aimed to show the feasibility and safety of percutaneous patent ductus arteriosus (PDA) closure under echocardiography-only guidance during our 1-year experience.MethodsPatients with PDA were recruited for percutaneous PDA closure guided by either fluoroscopy or echocardiography-only in National Cardiovascular Center Harapan Kita (ClinicalTrials.gov Identifier: NCT05321849, clinicaltrials.gov/ct2/show/NCT05321849). Patients were evaluated clinically and radiologically using transthoracic echocardiography (TTE) at 6, 24, and 48 h after the procedure. The primary endpoint was the procedural success. Secondary endpoints were the procedural time and the rate of adverse events.ResultsA total of 60 patients underwent transcatheter PDA closure, 30 patients with fluoroscopy and 30 patients with echocardiography guidance. All patients had successful PDA closure. There were only residual shunts, which were disappeared after follow-up in both groups, but one patient with a fluoroscopy-guided procedure had moderate tricuspid regurgitation with suspected thrombus in the tricuspid valve. The procedural time was not significantly different between the fluoroscopy and echocardiography groups.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Echocardiography-Guided Percutaneous Patent Ductus Arteriosus Closure: 1-Year Single Center Experience in Indonesia

Siagian

Prakoso

Putra

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…The current study demonstrated successful transcatheter ductal closure guided only by TTE. Previously published studies have demonstated acceptable reliability of this procedure [9,10]. Our research focused on PDA closure for pediatric patients under the guidance of TTE alone.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous device closure of pediatirc patent ductus arteriosus through femoral artery guidance by transthoracic echocardiography without radiation and contrast agents

et al. 2020

J Cardiothorac Surg

View full text Add to dashboard Cite

Background: For many years, percutaneous interventional occlusion of congenital patent ductus arteriosus (PDA) has been completed using radiation and contrast agents. In this study, transthoracic echocardiography without radiation and contrast agents was used to complete percutaneous occlusion of pediatric PDA. Methods: Thirty-two children (8 males and 24 females) with normal heart function and no other intracardiac deformities were diagnosed with PDA (20 funnel type; 12 tube type), One patient had peripheral facial paralysis, 1 patient had epilepsy, and 1 case had multiple cervical deformities. All procedures were performed in the surgical operating room (without Digital Subtraction Angiography (DSA) equipment) under basic anesthesia through the femoral artery pathway. The procedures were guided by transthoracic echocardiography (TTE) by establishing an orbit with a catheter through the femoral artery to thepatent ductus arteriosus,pulmonary artery and right ventricle. A suitable ventricular septal defect occluder was placed using the femoral artery approach,and the treatment effect was evaluated by echocardiography after occlusion. The Outpatient follow-up was performed at 1, 3 months after the operation. Results: All cases had successful closure of PDA, which took only 35.6 ± 6.4 min. The diameter of the device was 4.8 ± 2.3 mm, and the heart murmur disappeared. There was no shunt between the left pulmonary artery and the descending aortic artery, and the length of hospitalization was 3.4 ± 0.5 days. No other incisions were needed in 32 cases. No occluder was removed, and no residual shunt was found after operation; moreover, no ICU stay was needed, and the mean hospital stay was 3.4 ± 0.5 days. No residual shunt was found at the 1-, 3-month follow-up visit.

show abstract

“…Oto et al ( 15 ) demonstrated the efficacy and safety of TTE guidance during percutaneous device closure of patent foramen ovale, demonstrating a shortened procedural time without the need for general anesthesia or endotracheal intubation. We also used TTE to guide transthoracic device closure of ASDs and transcatheter device closure of patent ductus arteriosus with satisfactory results ( 16 , 17 ). Increasing the number of investigators confirmed that TTE can be used as a reliable tool for guidance during device closure by skilled hands.…”

Section: Discussionmentioning

confidence: 99%

Transcatheter device closure of atrial septal defect guided by totally transthoracic echocardiography, a single cardiac center experience on 152 cases

Chen

Cao

Zhang³

et al. 2018

Anatol J Cardiol

View full text Add to dashboard Cite

Objective:This study aimed to assess the safety and feasibility of transcatheter device closure of atrial septal defects (ASDs) guided completely by transthoracic echocardiography (TTE).Methods:A total of 152 patients underwent transcatheter device closure of ASDs guided completely by TTE in our center from September 2014 to June 2017. We used routine delivery sheaths during the procedure and then closed the ASDs by releasing a domestic occluder.Results:The closure was successful in 150 patients, and surgical repair was required in two patients. The size of the deployed occluder ranged from 10 mm to 38 mm (21.4±8.5 mm), and the procedure duration ranged from 30 to 90 min (38.2±21.4 min). No fatal complications were observed. Minor complications included transient arrhythmias (n=12) during the process of device deployment. The follow-up period was 3 months to 2 years, with no occluder dislodgment, residual fistula, or thrombus-related complications. In our comparative studies, no statistically significant differences were observed in success rates and complications.Conclusion:Transcatheter device closure of ASDs guided completely by TTE may be safe and effective and can be an alternative to traditional methods.

show abstract

Clinical study of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patent ductus arteriosus

Cited by 6 publications

References 24 publications

Echocardiography-Guided Percutaneous Patent Ductus Arteriosus Closure: 1-Year Single Center Experience in Indonesia

Echocardiography-Guided Percutaneous Patent Ductus Arteriosus Closure: 1-Year Single Center Experience in Indonesia

Percutaneous device closure of pediatirc patent ductus arteriosus through femoral artery guidance by transthoracic echocardiography without radiation and contrast agents

Transcatheter device closure of atrial septal defect guided by totally transthoracic echocardiography, a single cardiac center experience on 152 cases

Contact Info

Product

Resources

About